Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A00147-44 | Other Identifier | ANSM |
Not provided
Not provided
Due to logistical concerns
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic demyelinating polyneuropathy of autoimmune origin with a progressive or relapsing course.
Diagnosis is based on clinical presentation and electrophysiological findings in accordance with the EFNS/PNS consensus guidelines. IVIg is the first line treatment witch has been shown to be effective in several placebo-controlled trials.
Once IVIg therapy produces a response and is well tolerated, some patients are able to continue their treatment in the home setting. The HOME LINK system offers an integrated, global solution based on telemonitoring technology providing continuous, remote monitoring of Privigen® infusions administered at home.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HOME LINK | Device | Telemonitoring system which include web platform and connected devices. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate HOME LINK telemonitoring system for patients receiving home-based IVIg therapy | The conventional method of home monitoring requires using a visiting nurse. HOME LINK is a telemonitoring system that is an alternative to this conventional method offering remote at-home monitoring. HOME LINK monitors the patient's health parameters from home. In this way it enables an adjustment of the infusion conditions or intervention of a qualified healthcare professional in the event of an incident. Home Link will be evaluated for failure rate of connection to the telemonitoring platform, failure rate of transmission of self-measurements to the telemonitoring platform, failure rate of transmission of documents relating to home-based treatment, and failure rate of contacting one of the healthcare professionals involved in patient care during the at-home infusions. | 52 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients receiving home-based IVIg therapy with Privigen
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Pellegrin, Bordeaux University Hospital (CHU) | Bordeaux | France | ||||
| Hôpital Henri Mondor - APHP |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020277 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating |
| ID | Term |
|---|---|
| D011129 | Polyradiculoneuropathy |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Créteil |
| France |
| Hôpital Roger Salengro - CHRU | Lille | France |
| Hôpital Pierre Wertheimer - HCL | Lyon | France |
| Hôpital La Timone - APHM | Marseille | France |
| Hôpital Gui de Chauliac - Montpellier University Hospital (CHU) | Montpellier | France |
| Hôpital Pasteur 2 - Nice University Hospital (CHU) | Nice | France |
| Hôpital La Pitié-Salpêtrière - APHP | Paris | France |
| Hôpital Lariboisière - APHP | Paris | France |
| Hôpital Nord - Saint Etienne University Hospital (CHU) | Saint-Etienne | France |
| D011115 | Polyneuropathies |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |